Interleukin-6 as diagnostic marker for neonatal sepsis: Determination of access® IL-6 cutoff for newborns

Clinical Laboratory

Volumn 54, Issue 5-6, 2008, Pages 179-183

  Prinsen, Jan Hendrik ^a   Baranski, Ellen ^b   Posch, Hella ^c   Tober, Kerstin ^d   Gerstmeyer, Axel ^d  

^a Krankenhaus Bethanien   (Germany)

^b Rhön Kliniken Uelzen und Bad Bevensen   (Germany)

^c Ruppiner Kliniken GmbH   (Germany)

^d Asklepios Klinikum Uckermark   (Germany)

Author keywords

C reactive protein; Interleukin 6; Neonatal septicaemia

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ANALYZER; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; IMMUNOASSAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SEPSIS; NORMAL VALUE; PROTEIN BLOOD LEVEL; REFERENCE VALUE;

BIOLOGICAL MARKERS; HUMANS; INFANT, NEWBORN; INTERLEUKIN-6; REFERENCE VALUES; SEPSIS;

BACTERIA (MICROORGANISMS);

EID: 51049099536     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. WHO: World Health report. Geneva: World Health Organization, 2005.
2. Berner R, Niemeyer CM, Leititis JU, Funke A, Schwab C, Rau U, Richter K, Tawfeek MS, Clad A, Brandis M. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatric Research 1998; 44: 469-477.
3. Døllner H, Vatten L, Austgulen R. Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumor necrosis factor receptors and soluble adhesion molecules. J Clin Epidemiol 2001; 54: 1251-1257.
4. Hodge G, Hodge S, Haslam R et al. Rapid simultaneous measurement of multiple cytokines using 100 microl sample volumes association with neonatal sepsis. Clin Exp Immunol 2004; 137: 402-407.
5. Treszl A, Kocsis I, Szathmari M et al. Genetic variants of TNF-[FC12]a, IL-1beta, IL-4 receptor [FC12]a-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants. Biol Neonate 2003; 83: 241-245.
6. Baier RJ, Loggins J, Yanamandra K. IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants. BMC Med 2006; 4: 10.
7. Laborada G, Nesin M. Interleukin-6 and interleukin-8 are elevated in the cerebrospinal fluid of infants exposed to chorioamnionitis. Biol Neonate 2005; 88: 136-144.
8. Volante E, Moretti S, Pisani F, Bevilacqua G. Early diagnosis of bacterial infection in the neonate. J Matern Fetal Neonatal Med 2004; 16 (Suppl. 2): 13-16.
9. Procianoy RS, Silveira RC. The role of sample collection timing on interleukin-6 levels in early-onset neonatal sepsis. J Pediatr (Rio J) 2004; 80: 407-410.
10. Laborada G, Rego M, Jain A et al. Diagnostic value of cytokines and C-reactive protein in the first 24 h of neonatal sepsis. Am J Perinatol 2003; 20: 491-501.
11. Gonzalez BE, Mercado CK, Johnson L, Brodsky NL, Bhandari V. Early markers of late-onset sepsis in premature neonates: clinical, hematological and cytokine profile. J Perinat Med 2003; 31: 60-68.
12. Sikora JP, Chlebna-Sokol D, Krzyzanska-Oberbek A. Pro-inflammatory cytokines (IL-6, IL-8), cytokine inhibitors (IL-6sR, sTNFRII) and anti-inflammatory cytokines (IL-10, IL- 13) in the pathogenesis of sepsis in newborns and infants. Arch Immunol Ther Exp (Warsz) 2001; 49: 399-404.
13. Lopez Sastre JB, Perez Solis D, Roques Serradilla V et al. Procalcitonin is not sufficiently reliable to be the sole marker of neonatal sepsis of nosocomial origin. BMC Pediatr 2006; 6: 16.
14. Kashlan F, Smulian J, Shen-Schwarz S et al. Umbilical vein interleukin 6 and tumor necrosis factor alpha plasma concentrations in the very preterm infant. Pediatr Infect Dis J 2000; 19: 238-243.
15. Koc E, Ustundag G, Aliefendioglu D, Ergenekon E, Bideci A, Atalay Y. Serum leptin levels and their relationship to tumor necrosis factor-alpha and interleukin-6 in neonatal sepsis. J Pediatr Endocrinol Metab 2003; 16: 1283-7.
16. Kao PC, Shiesh SC, Wu TJ. Serum C-reactive protein as a marker for wellness assessment. Ann Clin Lab Sci 2006; 36: 163-169.
17. Sehgal PB, Wang L, Rayanade R, Pan H, Margulies. Interleukin-6-type cytokines. Ann N Y Acad Sci 1995; 762: 1-14.
18. Bowcock AM, Kidd JR, Lathrop GM, Daneshvar L, May LT, Ray A, Sehgal PB, Kidd KK, Cavalli-Sforza LL. The human "interferon-beta 2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics. 1988; 3: 8-16.
19. Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science. 1998;280: 243-248.
20. Janeway CR Jr. How the immune system works to protect the host from infection: a personal view. Proc Natl Acad Sci U S A. 2001; 98: 7461-7468.
21. Kushner I. Regulation of the acute phase response by cytokines. Perspect Biol Med. 1993; 36: 611-622.
22. Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC, Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 1989; 242: 237-239.
23. Arbeitsgemeinschaft der Wissensehaftlichen Medizinischen Fachgesellschaften. Leitlinien der Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin. Bakterielle Infektionen bei Neugeborenen. AWMF-Leitlinien-Register, Nr. 024/008.
24. Beckman Coulter. Technical Bulletin IL-6